ASTRON RESEARCH LIMITED Patent applications |
Patent application number | Title | Published |
20130303464 | STABLE READY-TO-USE CETRORELIX INJECTION - The present invention discloses a stable ready-to-use aqueous pharmaceutical preparation containing Cetrorelix or its pharmaceutically acceptable salt, wherein the preparation does not contain any surfactant. Further, the present invention discloses process for the preparation of said stable ready-to-use aqueous pharmaceutical preparation. | 11-14-2013 |
20120252835 | STABLE TEMSIROLIMUS COMPOSITION AND PROCESS OF PREPARING SAME - The present disclosure describes a stable composition of Temsirolimus for parenteral administration. The composition includes BHA or BHT as anti-oxidants and alcoholic solvent. The pH of the composition is below 5.0. The composition also can include a chelating agent and/or a surfactant. A method of producing the composition is also described. | 10-04-2012 |
20120129799 | STABLE COMPOSITION OF READY-TO-USE GEMCITABINE INJECTION - The present invention relates to non aqueous pharmaceutical preparations containing gemcitabine or its pharmaceutically, acceptable salts in the form of ready-to-use solutions wherein the concentration of Gemcitabine is in the range of about 16 mg/ml to about 200 mg/ml and a pH of about 3.5 to 10.0. Further, a method for the preparation of non-aqueous Gemcitabine solution of the present invention is also disclosed. | 05-24-2012 |
20100248376 | IN-VITRO METHOD FOR TESTING BIOEQUIVALENCE OF IRON-SUCROSE FORMULATION - The present disclosure relates to an in vitro method for measuring the T | 09-30-2010 |
20100178333 | SUSTAINED RELEASE DOSAGE FORM OF PHENOTHIAZINE DERIVATIVES CONTAINING CHANNELIZER - Once a day sustained release solid oral dosage form of phenothiazine derivative preferably the dibenzothiazepine derivative and their pharmaceutically acceptable salts comprising of a channelizer, rate controlling polymer and suitable pharmaceutically acceptable excipients. The formulation of the present invention is in the form of tablet or capsule which provides a sustained drug action upto 24 hours upon single dose administration. | 07-15-2010 |